Evidence map›Paper›PMID 38689770›Full record

ArticleFrontiers in public health2024

Prevalence, drug resistance, and genotypic diversity of the RD

Bernardo Castro-Rodriguez, Greta Franco-Sotomayor, Jose Manuel Benitez-Medina, Greta Cardenas-Franco, Natalia Jiménez-Pizarro, Camilo Cardenas-Franco, Juan Luis Aguirre-Martinez, Solon Alberto Orlando, Javier Hermoso de Mendoza, Miguel Angel Garcia-Bereguiain

Abstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Molecular epidemiology ofJournal of clinical tuberculosis and other mycobacterial diseases · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bernardo Castro-RodriguezOne Health Research Group, Universidad de las Américas, Quito, Ecuador.
Greta Franco-SotomayorInstituto Nacional de Investigación en Salud Pública "Leopoldo Izquieta Pérez", Guayaquil, Ecuador.
Jose Manuel Benitez-MedinaDepartamento de Sanidad Animal, Facultad de Veterinaria, Universidad de Extremadura, Cáceres, Spain.
Greta Cardenas-FrancoOne Health Research Group, Universidad de las Américas, Quito, Ecuador.
Natalia Jiménez-PizarroDepartamento de Sanidad Animal, Facultad de Veterinaria, Universidad de Extremadura, Cáceres, Spain.
Camilo Cardenas-FrancoUniversidad Católica Santiago de Guayaquil, Guayaquil, Ecuador.
Juan Luis Aguirre-MartinezUniversidad Católica Santiago de Guayaquil, Guayaquil, Ecuador.
Solon Alberto OrlandoInstituto Nacional de Investigación en Salud Pública "Leopoldo Izquieta Pérez", Guayaquil, Ecuador.
Javier Hermoso de MendozaDepartamento de Sanidad Animal, Facultad de Veterinaria, Universidad de Extremadura, Cáceres, Spain.
Miguel Angel Garcia-BereguiainOne Health Research Group, Universidad de las Américas, Quito, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: A major sublineage within the Methods: A total of 814 MTB isolates from years 2012 to 2016 were screened by multiplex PCR for RD Results: A total number of 17 MTB RD Discussion: This is the first report of the prevalence of MTB RD

Indexed as

GenotypeMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAdolescentAdultAntitubercular AgentsDrug Resistance, Multiple, BacterialEcuadorFemaleGenetic VariationHumansMaleMiddle AgedPrevalenceRetrospective StudiesAntitubercular AgentsEcuadorMIRU-VNTRMycobacterium tuberculosisRDRio subfamilySpoligotypingtuberculosis

Identifiers

PMID38689770
PMCPMC11060180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.